Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 308

1.

Reduced incidence of preterm delivery with metronidazole and erythromycin in women with bacterial vaginosis.

Hauth JC, Goldenberg RL, Andrews WW, DuBard MB, Copper RL.

N Engl J Med. 1995 Dec 28;333(26):1732-6.

2.

Metronidazole to prevent preterm delivery in pregnant women with asymptomatic bacterial vaginosis. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units.

Carey JC, Klebanoff MA, Hauth JC, Hillier SL, Thom EA, Ernest JM, Heine RP, Nugent RP, Fischer ML, Leveno KJ, Wapner R, Varner M.

N Engl J Med. 2000 Feb 24;342(8):534-40.

3.

Randomized clinical trial of metronidazole plus erythromycin to prevent spontaneous preterm delivery in fetal fibronectin-positive women.

Andrews WW, Sibai BM, Thom EA, Dudley D, Ernest JM, McNellis D, Leveno KJ, Wapner R, Moawad A, O'Sullivan MJ, Caritis SN, Iams JD, Langer O, Miodovnik M, Dombrowski M; National Institute of Child Health & Human Development Maternal-Fetal Medicine Units Network.

Obstet Gynecol. 2003 May;101(5 Pt 1):847-55.

PMID:
12738139
4.

Impact of metronidazole therapy on preterm birth in women with bacterial vaginosis flora (Gardnerella vaginalis): a randomised, placebo controlled trial.

McDonald HM, O'Loughlin JA, Vigneswaran R, Jolley PT, Harvey JA, Bof A, McDonald PJ.

Br J Obstet Gynaecol. 1997 Dec;104(12):1391-7.

PMID:
9422018
5.
6.

Sexual intercourse association with asymptomatic bacterial vaginosis and Trichomonas vaginalis treatment in relationship to preterm birth.

Berghella V, Klebanoff M, McPherson C, Carey JC, Hauth JC, Ernest JM, Heine RP, Wapner RJ, Trout W, Moawad A, Leveno KJ, Miodovnik M, Sibai BM, Van Dorsten JP, Dombrowski MP, O'Sullivan MJ, Varner M, Langer O; National Institute for Child Health and Development Maternal Fetal Medicine Units Network.

Am J Obstet Gynecol. 2002 Nov;187(5):1277-82.

PMID:
12439520
7.

Vaginal clindamycin in preventing preterm birth and peripartal infections in asymptomatic women with bacterial vaginosis: a randomized, controlled trial.

Kekki M, Kurki T, Pelkonen J, Kurkinen-Räty M, Cacciatore B, Paavonen J.

Obstet Gynecol. 2001 May;97(5 Pt 1):643-8.

PMID:
11339909
8.

Failure of metronidazole to prevent preterm delivery among pregnant women with asymptomatic Trichomonas vaginalis infection.

Klebanoff MA, Carey JC, Hauth JC, Hillier SL, Nugent RP, Thom EA, Ernest JM, Heine RP, Wapner RJ, Trout W, Moawad A, Leveno KJ, Miodovnik M, Sibai BM, Van Dorsten JP, Dombrowski MP, O'Sullivan MJ, Varner M, Langer O, McNellis D, Roberts JM; National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units.

N Engl J Med. 2001 Aug 16;345(7):487-93.

9.

Effect of metronidazole in patients with preterm birth in preceding pregnancy and bacterial vaginosis: a placebo-controlled, double-blind study.

Morales WJ, Schorr S, Albritton J.

Am J Obstet Gynecol. 1994 Aug;171(2):345-7; discussion 348-9.

PMID:
8059811
10.

Bacterial vaginosis in pregnancy and efficacy of short-course oral metronidazole treatment: a randomized controlled trial.

McDonald HM, O'Loughlin JA, Vigneswaran R, Jolley PT, McDonald PJ.

Obstet Gynecol. 1994 Sep;84(3):343-8.

PMID:
8058228
11.

Reduced incidence of preterm delivery with metronidazole and erythromycin in women with bacterial vaginosis.

Steele RW.

Clin Pediatr (Phila). 1996 Jul;35(7):378-9. Review. No abstract available.

PMID:
8829012
12.

Bacterial vaginosis is associated with prematurity and vaginal fluid mucinase and sialidase: results of a controlled trial of topical clindamycin cream.

McGregor JA, French JI, Jones W, Milligan K, McKinney PJ, Patterson E, Parker R.

Am J Obstet Gynecol. 1994 Apr;170(4):1048-59; discussion 1059-60.

PMID:
8166188
13.

Treatment of sexually transmitted bacterial diseases in pregnant women.

Donders GG.

Drugs. 2000 Mar;59(3):477-85. Review.

PMID:
10776830
14.

Cervicovaginal microflora and pregnancy outcome: results of a double-blind, placebo-controlled trial of erythromycin treatment.

McGregor JA, French JI, Richter R, Vuchetich M, Bachus V, Seo K, Hillier S, Judson FN, McFee J, Schoonmaker J, et al.

Am J Obstet Gynecol. 1990 Nov;163(5 Pt 1):1580-91.

PMID:
2240110
15.

Adjunctive clindamycin therapy for preterm labor: results of a double-blind, placebo-controlled trial.

McGregor JA, French JI, Seo K.

Am J Obstet Gynecol. 1991 Oct;165(4 Pt 1):867-75.

PMID:
1951545
16.

Outcome of the Vaginal Infections and Prematurity Study: results of a clinical trial of erythromycin among pregnant women colonized with group B streptococci.

Klebanoff MA, Regan JA, Rao AV, Nugent RP, Blackwelder WC, Eschenbach DA, Pastorek JG 2nd, Williams S, Gibbs RS, Carey JC.

Am J Obstet Gynecol. 1995 May;172(5):1540-5.

PMID:
7755068
17.

What have we learned about vaginal infections and preterm birth?

Carey JC, Klebanoff MA; National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network.

Semin Perinatol. 2003 Jun;27(3):212-6. Review.

PMID:
12889588
18.

Impact of treatment for bacterial vaginosis on prematurity among Brazilian pregnant women: a retrospective cohort study.

Camargo RP, Simões JA, Cecatti JG, Alves VM, Faro S.

Sao Paulo Med J. 2005 May 2;123(3):108-12. Epub 2005 Jul 8.

19.
20.

Is inflammation on Papanicolaou smear a risk factor for preterm delivery?

Lanouette JM, Puder KS, Berry SM, Bryant DR, Dombrowski MP.

Fetal Diagn Ther. 1997 Jul-Aug;12(4):244-7.

PMID:
9354886

Supplemental Content

Support Center